LON:COSCollagen Solutions Share Price, Forecast & News

GBX 3.25

+0.05 (+1.56 %)

(As of 06/5/2020 04:00 PM ET)

Add

Compare

Today's Range

3.16

Now: GBX 3.25▼

3.38

50-Day Range

1.10

MA: GBX 2.41▼

3.25

52-Week Range

0.70

Now: GBX 3.25▼

5.40

Volume344,367 shs

Average Volume293,832 shs

Market Capitalization£14.42 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Collagen Solutions plc sources, develops, manufactures, and supplies medical grade collagen components and biomaterials for use in research, regenerative medicines, medical devices, and in-vitro diagnostics in Europe, the Middle East, Africa, North America, and Asia. It offers collagen soluble collagen, collagen powders, fibrillars, collagen gels, freeze dried collagen, and other products for use in orthopaedic, sports medicine, dental, wound care, cardiovascular, general, plastic, and reconstructive surgeries, as well as 3D cell culture research; Bovine Pericardium is used in bio-prosthetic heart valves, dural closures, bone and dental membranes, and surgical buttressing applications; and BSE-free bovine biomaterials. The company also provides product development and contract manufacturing services, including technology transfer and regulatory support services for collagen-based products. It serves pharmaceutical and medical device companies. Collagen Solutions plc was incorporated in 2013 and is based in London, the United Kingdom.

Beat the Market (BTM) Rank^™

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Collagen Solutions.

2.9 Community Rank

Outperform Votes
Collagen Solutions has received 129 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Collagen Solutions has received 97 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Collagen Solutions has received 57.08% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Collagen Solutions and other stocks. Vote “Outperform” if you believe COS will outperform the S&P 500 over the long term. Vote “Underperform” if you believe COS will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Collagen Solutions does not currently pay a dividend.
Dividend Growth
Collagen Solutions does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Collagen Solutions insiders have not sold or bought any company stock.

0.6 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Collagen Solutions is -7.90, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Collagen Solutions is -7.90, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Collagen Solutions has a P/B Ratio of 0.64. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

0.71 out of 5 stars

Industry, Sector and Symbol

Stock Exchange LON

Industry Biotechnology

Sub-IndustryN/A

SectorMedical

Current SymbolLON:COS

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.collagensolutions.com

Phone+44-141-6489100

Debt

Debt-to-Equity Ratio9.51

Current Ratio2.32

Quick Ratio2.16

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales£4.43 million

Price / Sales3.25

Cash FlowGBX 1.30 per share

Price / Cash Flow2.50

Book ValueGBX 5.10 per share

Price / Book0.64

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Employees48

Outstanding Shares443,683,008

Market Cap£14.42 million

Next Earnings DateN/A

OptionableNot Optionable

Receive COS News and Ratings via Email

Sign-up to receive the latest news and ratings for COS and its competitors with MarketBeat's FREE daily newsletter.

Collagen Solutions (LON:COS) Frequently Asked Questions

How has Collagen Solutions' stock been impacted by COVID-19 (Coronavirus)?

Collagen Solutions' stock was trading at GBX 2.20 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, COS shares have increased by 47.7% and is now trading at GBX 3.25. View which stocks have been most impacted by Coronavirus.

Has Collagen Solutions been receiving favorable news coverage?

News coverage about COS stock has trended very negative recently, according to InfoTrie. InfoTrie identifies positive and negative news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Collagen Solutions earned a daily sentiment score of -3.7 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the next several days. View the latest news aboutCollagen Solutions.

Who are some of Collagen Solutions' key competitors?

Some companies that are related to Collagen Solutions include e-Therapeutics (ETX), Emerald Health Therapeutics (EMH), Promis Neurosciences (PMN), Navidea Biopharmaceuticals (NAVB), Medlab Clinical (MDC), OptiBiotix Health (OPTI), Verona Pharma (VRP), Cocrystal Pharma (COCP), Protalix Biotherapeutics (PLX), Aerpio Pharmaceuticals (ARPO), Memphasys (MEM), Zelda Therapeutics (ZLD), ReNeuron Group (RENE), Botanix Pharmaceuticals (BOT) and Covalon Technologies (COV). View all competitors.

What other stocks do shareholders of Collagen Solutions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Collagen Solutions investors own include ReNeuron Group (RENE), Sareum (SAR), Oxford BioMedica (OXB), ValiRx (VAL), Oxford Instruments (OXIG), Active Energy Group (AEG), Norcros (NXR), Proteome Sciences (PRM), Perseus Mining (PRU) and Motif Bio (MTFB).

Who are Collagen Solutions' key executives?

Collagen Solutions' management team includes the following people:

Mr. Jamal D. Rushdy, CEO & Director (Age 47)
Ms. Hilary G. Spence, CFO & Director
Ms. Gillian Nancy Black, Company Sec. & VP of Global Fin. (Age 56)
Dr. Stewart White Ph.D., MBA, Consultant & Member of Scientific Advisory Board (Age 48)
Mr. Tom Hyland, COO, Director & Member of Scientific Advisory Board (Age 53)

What is Collagen Solutions' stock symbol?

Collagen Solutions trades on the London Stock Exchange (LON) under the ticker symbol "COS."

How do I buy shares of Collagen Solutions?

Shares of COS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Collagen Solutions' stock price today?

One share of COS stock can currently be purchased for approximately GBX 3.25.

How big of a company is Collagen Solutions?

Collagen Solutions has a market capitalization of £14.42 million and generates £4.43 million in revenue each year. Collagen Solutions employs 48 workers across the globe.

What is Collagen Solutions' official website?

The official website for Collagen Solutions is www.collagensolutions.com.

How can I contact Collagen Solutions?

Collagen Solutions' mailing address is Nova Business Park, 3 Robroyston Oval, GLASGOW, G33 1AP, United Kingdom. The company can be reached via phone at +44-141-6489100.

This page was last updated on 6/5/2020 by MarketBeat.com Staff

LON:COSCollagen Solutions Share Price, Forecast & News

Adding

Adding

Adding Collagen Solutions PLC

Beat the Market (BTM) Rank™